$514 Million is the total value of Octagon Capital Advisors LP's 28 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLDX | CELLDEX THERAPEUTICS INC NEW | $29,420,000 | -28.4% | 761,398 | 0.0% | 5.72% | -43.4% | |
| GOSS | GOSSAMER BIO INC | $17,114,000 | -10.0% | 1,513,138 | 0.0% | 3.33% | -28.9% | |
| RNA | AVIDITY BIOSCIENCES INC | $10,617,000 | -3.5% | 446,641 | 0.0% | 2.07% | -23.7% | |
| RXDX | PROMETHEUS BIOSCIENCES INC | $7,908,000 | +66.8% | 200,000 | 0.0% | 1.54% | +31.8% | |
| DYN | DYNE THERAPEUTICS INC | $6,940,000 | -26.8% | 583,649 | 0.0% | 1.35% | -42.1% | |
| CRDF | CARDIFF ONCOLOGY INC | $5,906,000 | -9.8% | 982,753 | 0.0% | 1.15% | -28.7% | |
| HLXA | HELIX ACQUISITION CORP | $3,956,000 | +0.2% | 400,000 | 0.0% | 0.77% | -20.8% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $3,063,000 | -8.3% | 150,000 | 0.0% | 0.60% | -27.6% | |
| JYAC | JIYA ACQUISITION CORP | $2,931,000 | -0.1% | 300,000 | 0.0% | 0.57% | -21.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 33.2% |
| ARCUS BIOSCIENCES INC | 12 | Q3 2023 | 18.1% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 10.1% |
| GOSSAMER BIO INC | 12 | Q3 2023 | 6.2% |
| 4D MOLECULAR THERAPEUTICS IN | 10 | Q1 2023 | 6.6% |
| BRIDGEBIO PHARMA INC | 10 | Q3 2023 | 6.6% |
| AVIDITY BIOSCIENCES INC | 10 | Q1 2023 | 3.8% |
| VERA THERAPEUTICS INC | 9 | Q2 2023 | 3.5% |
| DYNE THERAPEUTICS INC | 9 | Q3 2023 | 3.5% |
| STOKE THERAPEUTICS INC | 9 | Q2 2023 | 3.7% |
View Octagon Capital Advisors LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-05 |
| SC 13G | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-25 |
| 13F-HR | 2022-11-14 |
View Octagon Capital Advisors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.